Oscar
erlotinib (erlotinib)
Drugs for Cancer : Drugs for Cancer
  • Quantity Limit: limit maximum 3 EA PER fill retail
  • PID: Immune Globulin:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: Unspecified
    Documented inability to mount an immune response: Yes
    Documentation of severe infection despite prophylactic ABX treatment: No
    Documented Serum IgG Level: N/A
    IgG Subclass Level Referencing Standard Deviation Below Age Adjusted Mean: N/A
    Supporting Documentation Requirements: Medical Tests

  • PA Required